EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025

Cristobal Rodríguez-Leal iD, Berta Laguna-Fonseca, Francisco Javier Candel iD, Montserrat Rodríguez-Aguirregabiria, Juan Manuel García-Lechuz iD, Fátima Galán-Sánchez iD, Cruz Soriano-Cuesta, Ángel Estella iD, collaborative authors and Medical Societies for the 7th edition of Pneumonia Day (Addenda)

Revista Española de Quimioterapia · 08.07.2026 · 39 (4) · 287

DOI: 10.37201/req/150.2026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Revista Española de Quimioterapia, online erschienen am 15.05.2026. Verfasst von Cristobal Rodríguez-Leal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Medicine Service, Hospital Universitario del Henares, Coslada, Madrid, Spain. Hauptthemen laut MEDLINE: Pneumonia. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pneumonia is the leading cause of death from infection in the developed world. In recent years, researchers and healthcare professionals have worked tirelessly to address this issue. Multiresistance is a significant problem in severe pneumonia, so it is crucial to select the appropriate antibiotic at the correct dose and via the appropriate route of administration to ensure effective concentrations in the lung parenchyma. The diagnosis of pneumonia can also be challenging, so it is vital that imaging techniques, biomarkers, and microbiological methods are employed properly. An appropriate therapeutic approach is vital for managing severe community-acquired pneumonia, as it can be complex and is key to achieving optimal clinical outcomes. Nosocomial pneumonia also requires optimal management to avoid therapeutic failure and to improve outcomes, particularly in post-surgery patients. Not only bacteria, but also viruses and fungi can cause severe pneumonia, and appropriate diagnosis is essential for proper treatment. Finally, the correct use of new antimicrobial molecules can help to improve the clinical outcomes of these patients. To provide an update on these issues, a multidisciplinary team of Spanish experts met at the Seventh Annual Pneumonia Day Meeting, which was sponsored by the Grupo de Estudio de Infección en el Paciente Crítico (GEIPC) of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). This paper summarises the discussions held at the meeting and offers the latest insights on these topics, providing guidance on overcoming the challenges associated with pneumonia management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumoniaHumansCommunity-Acquired PneumoniaAnti-Bacterial AgentsCross InfectionHealthcare-Associated PneumoniaSpainPneumonia, BacterialCommunity-Acquired Infections

Stichwörter der Autor:innen

AetiologyCommunity acquired pneumoniaHealthcare-associated pneumoniaManagementTherapeutic failureVentilator-associated pneumonia, epidemiology, treatment

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Emergency Medicine Service, Hospital Universitario del Henares, Coslada, Madrid, Spain.
  • Fundación para la Investigación e Innovación Biomédica del Hospital Universitario del Henares (FIIB HUIS HHEN), Madrid, Spain.
  • Clinical Microbiology and Infectious Diseases, Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Instituto de Medicina del Laboratorio (IML), Madrid, Spain.
  • Instituto de Investigación Sanitaria, Hospital Clínico San Carlos (IdISSC), Instituto de Medicina del Laboratorio (IML), Madrid, Spain. fj.candel@gmail.com.
  • Intensive Care Medicine Department, Hospital General Universitario La Paz, Madrid, Spain.

ORCID-Profile: Cristobal Rodríguez-Leal, Francisco Javier Candel, Juan Manuel García-Lechuz, Fátima Galán-Sánchez, Ángel Estella

Zitieren

APA

Rodríguez-Leal, C., Laguna-Fonseca, B., Candel, F. J., Rodríguez-Aguirregabiria, M., García-Lechuz, J. M., Galán-Sánchez, F., Soriano-Cuesta, C., Estella, Á., & collaborative authors and Medical Societies for the 7th edition of Pneumonia Day (Addenda) (2026). Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025. Revista Española de Quimioterapia, 39(4), 287. https://doi.org/10.37201/req/150.2026

Vancouver

Rodríguez-Leal C, Laguna-Fonseca B, Candel FJ, Rodríguez-Aguirregabiria M, García-Lechuz JM, Galán-Sánchez F, et al. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025. Revista Española de Quimioterapia. 2026;39(4):287. doi:10.37201/req/150.2026

BibTeX
@article{RodrguezLeal2026,
  author = {Rodríguez-Leal, Cristobal and Laguna-Fonseca, Berta and Candel, Francisco Javier and Rodríguez-Aguirregabiria, Montserrat and García-Lechuz, Juan Manuel and Galán-Sánchez, Fátima and Soriano-Cuesta, Cruz and Estella, Ángel and collaborative authors and Medical Societies for the 7th edition of Pneumonia Day (Addenda), collaborative authors and Medical Societies for the 7th edition of Pneumonia Day (Addenda)},
  title = {Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025},
  journal = {Revista Española de Quimioterapia},
  year = {2026},
  volume = {39},
  number = {4},
  pages = {287},
  doi = {10.37201/req/150.2026}
}
Kostenlos starten →